LATAM Cryptococcosis Market Size & Outlook, 2026-2034


LATAM Cryptococcosis Market Insights

  • Based on Reed Intelligence findings, the LATAM Cryptococcosis Market size reached USD 38.42 Million in 2025 and is expected to grow to USD 68.7 Million by 2034.
  • During 2026–2034, the market is forecasted to advance at a CAGR of 6.72%.
  • Azoles represented the largest share of the By Drug Class market in terms of size in 2025.
  • Among the By Drug Class segments, Flucytosine is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • The global Cryptococcosis Market size saw LATAM holding a share of 5.65% in 2025.
  • United States is forecasted to account for the leading share of the global market by 2034.
  • In LATAM, Argentina is forecasted to be the fastest-expanding market, projected to reach USD 7.1 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 38.42 Million
Market Size In 2034 USD 68.7 Million
Largest segment Azoles
Units Revenue in USD Million
CAGR 6.72% (2026-2034)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
By Drug Class
  1. Azoles
  2. Polyenes
  3. Flucytosine
  4. Combination Therapy
By Indication
  1. Cryptococcal Meningitis
  2. Pulmonary Cryptococcosis
  3. Disseminated Cryptococcosis
By Route of Administration
  1. Oral
  2. Intravenous
By End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends